PubMed

A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP Study.

Simões EA, Carbonell-Estrany X, Fullarton JR, Liese JG, Figueras-Aloy J, Doering G, Guzman J; European RSV Risk Factor Study Group.

Respir Res. 2008 Dec 8;9:78.PMID: 19063742 [PubMed - indexed for MEDLINE]Related articlesFree article

Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain.

Figueras-Aloy J, Carbonell-Estrany X, Quero J; IRIS Study Group.

Pediatr Infect Dis J. 2004 Sep;23(9):815-20.PMID: 15361718 [PubMed - indexed for MEDLINE]Related articles

Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33-35 completed weeks' gestational age in Canada.

Paes B, Steele S, Janes M, Pinelli J.

Curr Med Res Opin. 2009 Jul;25(7):1585-91.PMID: 19469698 [PubMed - indexed for MEDLINE]Related articles

FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.

Figueras-Aloy J, Carbonell-Estrany X, Quero-Jiménez J, Fernández-Colomer B, Guzmán-Cabañas J, Echaniz-Urcelay I, Doménech-Martínez E; IRIS Study Group.

Pediatr Infect Dis J. 2008 Sep;27(9):788-93.PMID: 18664927 [PubMed - indexed for MEDLINE]Related articles

Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation.

Sampalis JS, Langley J, Carbonell-Estrany X, Paes B, O'Brien K, Allen U, Mitchell I, Aloy JF, Pedraz C, Michaliszyn AF.

Med Decis Making. 2008 Jul-Aug;28(4):471-80. Epub 2008 Jun 12.PMID: 18556643 [PubMed - indexed for MEDLINE]Related articles

[Usefulness of different risk factor associations in predicting admissions due to respiratory syncytial virus in premature newborns of 32 to 35 weeks gestation in Spain]

Figueras-Aloy J, Quero-Jiménez J, Fernández-Colomer B, Guzmán-Cabañas J, Echaniz-Urcelay I, Doménech-Martínez E; Grupo IRIS.

An Pediatr (Barc). 2009 Jul;71(1):47-53. Epub 2009 Jun 12. Spanish. PMID: 19524492 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age.

Carbonell-Estrany X, Bont L, Doering G, Gouyon JB, Lanari M.

Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):891-9. Epub 2008 Jul 16. Review.PMID: 18629558 [PubMed - indexed for MEDLINE]Related articles

Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.

Romero JR.

Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S46-54.PMID: 12671452 [PubMed - indexed for MEDLINE]Related articles

Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.

Pedraz C, Carbonell-Estrany X, Figueras-Aloy J, Quero J; IRIS Study Group.

Pediatr Infect Dis J. 2003 Sep;22(9):823-7.PMID: 14506376 [PubMed - indexed for MEDLINE]Related articles

Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany.

Liese JG, Grill E, Fischer B, Roeckl-Wiedmann I, Carr D, Belohradsky BH; Munich RSV Study Group.

Eur J Pediatr. 2003 Apr;162(4):230-6. Epub 2003 Mar 1.PMID: 12647195 [PubMed - indexed for MEDLINE]Related articles

Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.

Simoes EA, Carbonell-Estrany X.

Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S13-8; discussion S18-20.PMID: 12671448 [PubMed - indexed for MEDLINE]Related articles

The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation.

Law BJ, Langley JM, Allen U, Paes B, Lee DS, Mitchell I, Sampalis J, Walti H, Robinson J, O'Brien K, Majaesic C, Caouette G, Frenette L, Le Saux N, Simmons B, Moisiuk S, Sankaran K, Ojah C, Singh AJ, Lebel MH, Bacheyie GS, Onyett H, Michaliszyn A, Manzi P, Parison D.

Pediatr Infect Dis J. 2004 Sep;23(9):806-14.PMID: 15361717 [PubMed - indexed for MEDLINE]Related articles

Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis.

Stevens TP, Sinkin RA, Hall CB, Maniscalco WM, McConnochie KM.

Arch Pediatr Adolesc Med. 2000 Jan;154(1):55-61.PMID: 10632251 [PubMed - indexed for MEDLINE]Related articlesFree article

Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons.

Carbonell-Estrany X, Quero J; IRIS Study Group.

Pediatr Infect Dis J. 2001 Sep;20(9):874-9.PMID: 11734767 [PubMed - indexed for MEDLINE]Related articles

Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group.

Carbonell-Estrany X, Quero J, Bustos G, Cotero A, Doménech E, Figueras-Aloy J, Fraga JM, García LG, García-Alix A, Del Río MG, Krauel X, Sastre JB, Narbona E, Roqués V, Hernández SS, Zapatero M.

Pediatr Infect Dis J. 2000 Jul;19(7):592-7.PMID: 10917214 [PubMed - indexed for MEDLINE]Related articles

Identifying risk factors for severe respiratory syncytial virus among infants born after 33 through 35 completed weeks of gestation: different methodologies yield consistent findings.

Carbonell-Estrany X, Figueras-Aloy J, Law BJ; Infección Respiratoria Infantil por Virus Respiratorio Sincitial Study Group; Pediatric Investigators Collaborative Network on Infections in Canada Study Group.

Pediatr Infect Dis J. 2004 Nov;23(11 Suppl):S193-201.PMID: 15577573 [PubMed - indexed for MEDLINE]Related articles

Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants.

Singleton R, Dooley L, Bruden D, Raelson S, Butler JC.

Pediatr Infect Dis J. 2003 Jun;22(6):540-5.PMID: 12799511 [PubMed - indexed for MEDLINE]Related articles

Palivizumab: new indication. Moderate reduction in hospitalisation rate.

[No authors listed]

Prescrire Int. 2004 Dec;13(74):213-6.PMID: 15612142 [PubMed - indexed for MEDLINE]Related articles

Palivizumab outcomes registry data from Spain: Infección Respiratoria Infantil por Virus Respiratorio Sincitial (IRIS) Study Group.

Carbonell-Estrany X.

Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S55-7; discussion S57.PMID: 12671453 [PubMed - indexed for MEDLINE]Related articles

Guidelines for palivizumab prophylaxis: are they based on infant's risk of hospitalization for respiratory syncytial viral disease?

Elhassan NO, Stevens TP, Sorbero ME, Dick AW, Guillet R, Hall CB.

Pediatr Infect Dis J. 2003 Nov;22(11):939-43.PMID: 14614363 [PubMed - indexed for MEDLINE]Related articles